delayed graft function

Vifor Pharma and Angion Sign License Agreement for ANG-3777 in Nephrology Indications

St. Gallen, Switzerland & Uniondale, N.Y., United States:  Vifor Pharma acquires a worldwide license, excluding Greater China, to late-stage product ANG-3777 ANG-3777 is…

Read More »